Xia Jin
Concepts (259)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Dengue Virus | 10 | 2006 | 6 |
Why?
| HIV Infections | 21 | 1993 | 136 |
Why?
| HIV-1 | 28 | 1993 | 93 |
Why?
| T-Lymphocytes, Cytotoxic | 18 | 1993 | 52 |
Why?
| Dengue | 4 | 2007 | 5 |
Why?
| CD8-Positive T-Lymphocytes | 11 | 1999 | 91 |
Why?
| AIDS Vaccines | 6 | 2001 | 18 |
Why?
| Monocytes | 2 | 2008 | 124 |
Why?
| Epitopes, T-Lymphocyte | 3 | 2000 | 17 |
Why?
| Antibodies, Viral | 6 | 1996 | 104 |
Why?
| Virus Replication | 9 | 1999 | 90 |
Why?
| Cytomegalovirus | 5 | 1996 | 42 |
Why?
| Acquired Immunodeficiency Syndrome | 7 | 1998 | 85 |
Why?
| Interleukin-2 | 3 | 1998 | 71 |
Why?
| Antiretroviral Therapy, Highly Active | 4 | 2000 | 27 |
Why?
| Viremia | 9 | 1998 | 18 |
Why?
| CD4-Positive T-Lymphocytes | 7 | 1993 | 113 |
Why?
| Dengue Vaccines | 2 | 2009 | 3 |
Why?
| Antibody-Dependent Enhancement | 2 | 2007 | 5 |
Why?
| Neutralization Tests | 6 | 2001 | 37 |
Why?
| Staining and Labeling | 3 | 2005 | 101 |
Why?
| Interferon Type I | 1 | 2010 | 22 |
Why?
| Nucleoside Deaminases | 2 | 2005 | 10 |
Why?
| Parent-Child Relations | 2 | 2007 | 53 |
Why?
| Leukocytes, Mononuclear | 6 | 1996 | 67 |
Why?
| HIV Long-Term Survivors | 2 | 2000 | 3 |
Why?
| Succinimides | 2 | 2006 | 12 |
Why?
| Fluoresceins | 2 | 2006 | 50 |
Why?
| Simian immunodeficiency virus | 6 | 1999 | 12 |
Why?
| RNA, Viral | 11 | 1998 | 91 |
Why?
| T-Lymphocytes | 6 | 1999 | 182 |
Why?
| Hepatitis B, Chronic | 1 | 2008 | 2 |
Why?
| Humans | 44 | 1993 | 1856 |
Why?
| Flow Cytometry | 7 | 1998 | 216 |
Why?
| Repressor Proteins | 2 | 2005 | 96 |
Why?
| Gene Products, gag | 6 | 1993 | 14 |
Why?
| Stress, Psychological | 2 | 2007 | 117 |
Why?
| Immunity | 1 | 2008 | 46 |
Why?
| Disease Outbreaks | 1 | 2008 | 61 |
Why?
| Interferon-gamma | 3 | 2005 | 133 |
Why?
| Simian Acquired Immunodeficiency Syndrome | 3 | 1999 | 8 |
Why?
| Cell Division | 2 | 2006 | 273 |
Why?
| Spleen | 1 | 2007 | 129 |
Why?
| Parents | 1 | 2008 | 89 |
Why?
| Endothelial Cells | 1 | 2009 | 80 |
Why?
| Receptors, IgG | 5 | 2000 | 30 |
Why?
| Fluorescent Dyes | 1 | 2006 | 115 |
Why?
| Macrophages | 1 | 2007 | 148 |
Why?
| HIV Envelope Protein gp160 | 2 | 1996 | 5 |
Why?
| Vero Cells | 6 | 1996 | 20 |
Why?
| Viral Vaccines | 2 | 2000 | 35 |
Why?
| Cercopithecus aethiops | 6 | 1996 | 67 |
Why?
| CD4 Lymphocyte Count | 7 | 1998 | 50 |
Why?
| Cell Proliferation | 2 | 2006 | 227 |
Why?
| HLA-B35 Antigen | 1 | 2002 | 1 |
Why?
| Viral Load | 7 | 1998 | 53 |
Why?
| Dendritic Cells | 3 | 1998 | 60 |
Why?
| Cytotoxicity, Immunologic | 3 | 1993 | 54 |
Why?
| Proteins | 1 | 2005 | 192 |
Why?
| HLA-A Antigens | 2 | 1998 | 4 |
Why?
| Vaccines, DNA | 3 | 2001 | 16 |
Why?
| Cells, Cultured | 5 | 1998 | 447 |
Why?
| Antibodies, Neutralizing | 2 | 2009 | 11 |
Why?
| Immunodominant Epitopes | 1 | 2000 | 14 |
Why?
| HIV Antibodies | 5 | 1998 | 16 |
Why?
| Disease Progression | 4 | 1998 | 244 |
Why?
| Cytokines | 3 | 2005 | 207 |
Why?
| Anti-HIV Agents | 7 | 1998 | 44 |
Why?
| Herpesviridae Infections | 1 | 2000 | 25 |
Why?
| Adult | 18 | 1993 | 1317 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2000 | 243 |
Why?
| Vaccinia virus | 3 | 1999 | 22 |
Why?
| Infectious Disease Transmission, Vertical | 1 | 1998 | 27 |
Why?
| HIV Antigens | 5 | 1993 | 8 |
Why?
| Male | 19 | 1993 | 1553 |
Why?
| Animals | 17 | 1996 | 1031 |
Why?
| Viral Plaque Assay | 4 | 2006 | 18 |
Why?
| Female | 15 | 1993 | 1643 |
Why?
| Killer Cells, Natural | 2 | 2007 | 62 |
Why?
| Genetic Vectors | 3 | 1999 | 139 |
Why?
| Algorithms | 1 | 2000 | 226 |
Why?
| Macaca mulatta | 6 | 1999 | 71 |
Why?
| Herpesvirus 4, Human | 4 | 1993 | 34 |
Why?
| Vaccination | 5 | 2000 | 92 |
Why?
| Cytidine Deaminase | 2 | 2005 | 15 |
Why?
| Gene Products, env | 5 | 1993 | 5 |
Why?
| B-Lymphocytes | 3 | 1999 | 134 |
Why?
| Biological Markers | 2 | 2005 | 262 |
Why?
| Middle Aged | 9 | 1999 | 1161 |
Why?
| Immunity, Cellular | 2 | 1993 | 85 |
Why?
| Child, Preschool | 3 | 2007 | 554 |
Why?
| HIV Core Protein p24 | 4 | 1998 | 17 |
Why?
| Recombination, Genetic | 2 | 2002 | 78 |
Why?
| Lymphocyte Count | 2 | 1998 | 38 |
Why?
| Viral Envelope Proteins | 3 | 1996 | 26 |
Why?
| China | 2 | 2008 | 34 |
Why?
| gag Gene Products, Human Immunodeficiency Virus | 2 | 1998 | 5 |
Why?
| Child | 4 | 1999 | 749 |
Why?
| Fowlpox virus | 1 | 2011 | 2 |
Why?
| Virus Internalization | 1 | 2010 | 4 |
Why?
| Antigens, CD | 2 | 1999 | 128 |
Why?
| Virus Attachment | 1 | 2010 | 7 |
Why?
| Antibodies, Blocking | 1 | 2010 | 7 |
Why?
| Drug Carriers | 1 | 2011 | 17 |
Why?
| Interleukins | 1 | 2010 | 32 |
Why?
| Chronic Disease | 3 | 2006 | 267 |
Why?
| Immunoglobulin G | 2 | 2009 | 191 |
Why?
| RNA, Messenger | 3 | 1999 | 394 |
Why?
| Lymphocyte Depletion | 4 | 2000 | 29 |
Why?
| Dengue Hemorrhagic Fever | 1 | 2009 | 3 |
Why?
| Gene Products, nef | 2 | 1999 | 4 |
Why?
| Young Adult | 2 | 2009 | 380 |
Why?
| Peptides | 3 | 1996 | 154 |
Why?
| Liver Function Tests | 1 | 2008 | 25 |
Why?
| Platelet Count | 1 | 2008 | 39 |
Why?
| Cytomegalovirus Infections | 2 | 1996 | 39 |
Why?
| Family Health | 1 | 2008 | 69 |
Why?
| Age Distribution | 1 | 2008 | 127 |
Why?
| Immunity, Innate | 1 | 2008 | 60 |
Why?
| T-Cell Antigen Receptor Specificity | 1 | 2006 | 4 |
Why?
| Influenza A virus | 1 | 2009 | 63 |
Why?
| Double-Blind Method | 1 | 2009 | 274 |
Why?
| Cross-Sectional Studies | 2 | 1998 | 253 |
Why?
| Phytohemagglutinins | 1 | 2006 | 25 |
Why?
| Antigen-Antibody Complex | 1 | 2006 | 34 |
Why?
| Lymphocyte Activation | 2 | 2001 | 137 |
Why?
| Herpesvirus 6, Human | 1 | 2008 | 22 |
Why?
| Enzyme-Linked Immunosorbent Assay | 3 | 1999 | 224 |
Why?
| Cross Reactions | 3 | 1996 | 63 |
Why?
| Prevalence | 1 | 2008 | 281 |
Why?
| Prospective Studies | 2 | 2007 | 545 |
Why?
| Viral Proteins | 2 | 1996 | 71 |
Why?
| Genotype | 2 | 2002 | 175 |
Why?
| Influenza, Human | 1 | 2009 | 94 |
Why?
| Data Interpretation, Statistical | 1 | 2006 | 109 |
Why?
| Immunization | 1 | 2006 | 85 |
Why?
| HIV Seropositivity | 1 | 2005 | 24 |
Why?
| Models, Biological | 2 | 2007 | 410 |
Why?
| Cell Line | 6 | 1996 | 375 |
Why?
| Gene Expression Regulation | 1 | 2010 | 277 |
Why?
| Amino Acid Sequence | 2 | 1996 | 319 |
Why?
| Adolescent | 3 | 1999 | 891 |
Why?
| Muromegalovirus | 1 | 2003 | 2 |
Why?
| Proviruses | 2 | 1998 | 8 |
Why?
| Longitudinal Studies | 3 | 1998 | 195 |
Why?
| Computer Simulation | 2 | 2000 | 134 |
Why?
| Questionnaires | 1 | 2008 | 360 |
Why?
| Infant | 1 | 2008 | 464 |
Why?
| Molecular Sequence Data | 2 | 1996 | 404 |
Why?
| Epitopes | 2 | 1996 | 86 |
Why?
| Vaccines, Combined | 1 | 2002 | 9 |
Why?
| Sequence Deletion | 2 | 1998 | 88 |
Why?
| Aged, 80 and over | 1 | 2008 | 599 |
Why?
| Genes, env | 1 | 2000 | 8 |
Why?
| Genes, MHC Class I | 1 | 2000 | 11 |
Why?
| Polymorphism, Restriction Fragment Length | 1 | 2000 | 32 |
Why?
| Antigens, CD8 | 1 | 2000 | 25 |
Why?
| Clinical Trials as Topic | 1 | 2005 | 251 |
Why?
| HLA-B7 Antigen | 1 | 2000 | 2 |
Why?
| Epstein-Barr Virus Infections | 1 | 2000 | 13 |
Why?
| Genes, pol | 1 | 1999 | 5 |
Why?
| Ritonavir | 1 | 1999 | 10 |
Why?
| Enterotoxins | 1 | 1999 | 15 |
Why?
| Lamivudine | 1 | 1999 | 18 |
Why?
| Blood Donors | 1 | 1999 | 19 |
Why?
| Aged | 2 | 2007 | 988 |
Why?
| Zidovudine | 1 | 1999 | 23 |
Why?
| Receptors, Antigen, T-Cell | 1 | 1999 | 34 |
Why?
| Antigens, Viral | 2 | 1993 | 53 |
Why?
| HIV Protease Inhibitors | 1 | 1999 | 25 |
Why?
| United States | 1 | 2006 | 604 |
Why?
| Reverse Transcriptase Inhibitors | 1 | 1999 | 19 |
Why?
| Tumor Cells, Cultured | 1 | 2000 | 233 |
Why?
| Mice | 4 | 2006 | 623 |
Why?
| Viral Matrix Proteins | 1 | 1996 | 12 |
Why?
| Immediate-Early Proteins | 1 | 1996 | 18 |
Why?
| Hematopoietic Stem Cells | 1 | 1999 | 69 |
Why?
| Phosphoproteins | 1 | 1996 | 86 |
Why?
| Time Factors | 4 | 1993 | 896 |
Why?
| Drug Therapy, Combination | 3 | 1999 | 189 |
Why?
| Infant, Newborn | 1 | 1998 | 389 |
Why?
| Pregnancy | 1 | 1998 | 455 |
Why?
| Vaccines, Subunit | 1 | 2010 | 10 |
Why?
| HIV Envelope Protein gp120 | 2 | 1998 | 15 |
Why?
| Immunization, Secondary | 1 | 2011 | 31 |
Why?
| Pan troglodytes | 1 | 2009 | 13 |
Why?
| Antibodies, Monoclonal | 2 | 1996 | 241 |
Why?
| nef Gene Products, Human Immunodeficiency Virus | 2 | 1999 | 2 |
Why?
| Aedes | 1 | 2009 | 4 |
Why?
| Sensitivity and Specificity | 2 | 1998 | 427 |
Why?
| Automation | 1 | 2009 | 27 |
Why?
| Mice, Inbred BALB C | 1 | 2010 | 176 |
Why?
| HLA-A2 Antigen | 2 | 1996 | 8 |
Why?
| Models, Theoretical | 1 | 2009 | 124 |
Why?
| Recombinant Fusion Proteins | 1 | 2009 | 189 |
Why?
| Epidemiology | 1 | 2007 | 15 |
Why?
| Antiviral Agents | 1 | 2009 | 91 |
Why?
| Predictive Value of Tests | 1 | 2009 | 321 |
Why?
| Virus Cultivation | 1 | 2006 | 24 |
Why?
| Phagocytosis | 1 | 2006 | 51 |
Why?
| Gene Products, pol | 2 | 1993 | 3 |
Why?
| Antigens, Thy-1 | 1 | 2006 | 22 |
Why?
| COS Cells | 1 | 2006 | 73 |
Why?
| Cohort Studies | 1 | 2009 | 332 |
Why?
| Mutation, Missense | 1 | 2006 | 59 |
Why?
| Genes, Reporter | 1 | 2006 | 111 |
Why?
| Mutagenesis, Site-Directed | 1 | 2006 | 126 |
Why?
| Protein Structure, Tertiary | 1 | 2006 | 163 |
Why?
| Mice, Inbred C57BL | 1 | 2009 | 318 |
Why?
| Immunophenotyping | 1 | 2003 | 66 |
Why?
| Microscopy, Electron | 1 | 2003 | 178 |
Why?
| Transduction, Genetic | 1 | 2003 | 65 |
Why?
| Luminescent Proteins | 1 | 2003 | 67 |
Why?
| Green Fluorescent Proteins | 1 | 2003 | 105 |
Why?
| SAIDS Vaccines | 1 | 2001 | 2 |
Why?
| env Gene Products, Human Immunodeficiency Virus | 1 | 2001 | 6 |
Why?
| Lung | 1 | 2009 | 232 |
Why?
| Adjuvants, Immunologic | 1 | 2002 | 73 |
Why?
| Virus Latency | 1 | 2000 | 11 |
Why?
| Blotting, Western | 1 | 2003 | 275 |
Why?
| Vaccines, Attenuated | 1 | 2000 | 22 |
Why?
| Lymphoid Tissue | 1 | 2000 | 34 |
Why?
| Antigens, CD20 | 1 | 2000 | 12 |
Why?
| Gene Rearrangement, T-Lymphocyte | 1 | 1999 | 4 |
Why?
| DNA, Circular | 1 | 1999 | 13 |
Why?
| Mutation | 1 | 2006 | 340 |
Why?
| NAD+ Nucleosidase | 1 | 1999 | 6 |
Why?
| ADP-ribosyl Cyclase | 1 | 1999 | 6 |
Why?
| Antigens, CD38 | 1 | 1999 | 7 |
Why?
| Concanavalin A | 1 | 1999 | 25 |
Why?
| Homosexuality, Male | 1 | 1999 | 13 |
Why?
| Antigens, Differentiation | 1 | 1999 | 53 |
Why?
| DNA, Viral | 1 | 2000 | 98 |
Why?
| Lymph Nodes | 1 | 2000 | 106 |
Why?
| Cytopathogenic Effect, Viral | 1 | 1998 | 19 |
Why?
| Recurrence | 1 | 2000 | 261 |
Why?
| Coloring Agents | 1 | 1998 | 42 |
Why?
| DNA Primers | 1 | 1999 | 208 |
Why?
| Oligopeptides | 1 | 1998 | 56 |
Why?
| Pilot Projects | 1 | 1999 | 264 |
Why?
| Case-Control Studies | 1 | 1999 | 283 |
Why?
| Cell Movement | 1 | 1999 | 163 |
Why?
| Cell Line, Transformed | 1 | 1996 | 52 |
Why?
| Immunologic Memory | 1 | 1998 | 51 |
Why?
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 1996 | 18 |
Why?
| Survivors | 1 | 1998 | 45 |
Why?
| Polymerase Chain Reaction | 1 | 1999 | 279 |
Why?
| HLA Antigens | 1 | 1996 | 38 |
Why?
| Antigen Presentation | 1 | 1996 | 28 |
Why?
| Alleles | 1 | 1996 | 108 |
Why?
| Recombinant Proteins | 1 | 1999 | 290 |
Why?
| Cricetinae | 1 | 1996 | 130 |
Why?
| Membrane Glycoproteins | 1 | 1999 | 154 |
Why?
| Kinetics | 1 | 1999 | 349 |
Why?
| Base Sequence | 1 | 1999 | 371 |
Why?
| Gene Expression | 1 | 1998 | 291 |
Why?
| DNA | 1 | 1999 | 262 |
Why?
| Aging | 1 | 1999 | 275 |
Why?
| Leukocyte Count | 1 | 1993 | 94 |
Why?
|
|
Jin's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
